Globus Free Cash Flow Yield vs Capex To Revenue Analysis

GMED Stock  USD 83.02  1.40  1.66%   
Globus Medical financial indicator trend analysis is much more than just examining Globus Medical latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Globus Medical is a good investment. Please check the relationship between Globus Medical Free Cash Flow Yield and its Capex To Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Free Cash Flow Yield vs Capex To Revenue

JavaScript chart by amCharts 3.21.152014201620182020202220240.0150.020.0250.030.0350.040.0450.05 0.050.0550.060.0650.070.0750.080.085
JavaScript chart by amCharts 3.21.15Free Cash Flow Yieldtotal: 0.3453271141020242Capex To Revenuetotal: 0.8674465298576279

Free Cash Flow Yield vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Globus Medical Free Cash Flow Yield account and Capex To Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.
Free Cash Flow YieldCapex To RevenueDiversified AwayFree Cash Flow YieldCapex To RevenueDiversified Away100%
The correlation between Globus Medical's Free Cash Flow Yield and Capex To Revenue is -0.43. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Globus Medical, assuming nothing else is changed. The correlation between historical values of Globus Medical's Free Cash Flow Yield and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Globus Medical are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Free Cash Flow Yield i.e., Globus Medical's Free Cash Flow Yield and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.43
Relationship DirectionNegative 
Relationship StrengthVery Weak

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most indicators from Globus Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.The current year's Selling General Administrative is expected to grow to about 675.6 M, whereas Tax Provision is forecasted to decline to about 34.9 M.
 2021 2022 2023 2024 (projected)
Gross Profit718.9M759.1M1.0B533.4M
Total Revenue958.1M1.0B1.6B1.6B

Globus Medical fundamental ratios Correlations

0.70.490.630.690.730.70.680.720.270.830.760.540.690.540.550.90.680.990.530.650.750.580.590.660.74
0.70.930.960.991.00.841.00.790.670.580.960.931.00.810.590.671.00.710.950.990.990.980.970.981.0
0.490.930.950.950.910.670.940.610.820.260.880.920.940.680.40.40.950.521.00.960.890.990.990.90.92
0.630.960.950.980.950.830.960.730.770.440.920.880.960.720.550.60.960.660.970.970.930.970.980.950.96
0.690.990.950.980.990.830.990.770.730.530.960.910.990.760.550.630.990.710.970.990.980.990.980.970.99
0.731.00.910.950.990.860.990.810.630.630.960.921.00.830.620.70.990.730.930.990.990.960.960.981.0
0.70.840.670.830.830.860.820.90.420.710.790.710.830.670.660.780.810.70.730.820.830.770.770.90.86
0.681.00.940.960.990.990.820.770.680.560.950.931.00.820.590.651.00.690.960.990.990.980.980.970.99
0.720.790.610.730.770.810.90.770.310.780.750.690.780.720.630.830.770.710.660.770.790.710.70.850.8
0.270.670.820.770.730.630.420.680.31-0.030.680.530.670.290.020.140.70.320.80.710.610.760.780.640.66
0.830.580.260.440.530.630.710.560.78-0.030.610.410.570.640.660.930.550.790.310.50.650.410.390.590.6
0.760.960.880.920.960.960.790.950.750.680.610.830.950.770.510.680.970.770.890.950.960.930.920.940.97
0.540.930.920.880.910.920.710.930.690.530.410.830.930.810.580.50.920.550.930.940.90.940.930.890.91
0.691.00.940.960.991.00.831.00.780.670.570.950.930.810.580.651.00.690.960.990.990.980.980.980.99
0.540.810.680.720.760.830.670.820.720.290.640.770.810.810.70.670.810.540.70.780.850.750.730.810.8
0.550.590.40.550.550.620.660.590.630.020.660.510.580.580.70.720.550.540.440.560.640.490.480.550.61
0.90.670.40.60.630.70.780.650.830.140.930.680.50.650.670.720.630.880.450.60.710.520.520.670.7
0.681.00.950.960.990.990.811.00.770.70.550.970.921.00.810.550.630.690.960.990.980.980.980.970.99
0.990.710.520.660.710.730.70.690.710.320.790.770.550.690.540.540.880.690.560.660.750.610.610.670.74
0.530.951.00.970.970.930.730.960.660.80.310.890.930.960.70.440.450.960.560.980.910.991.00.920.94
0.650.990.960.970.990.990.820.990.770.710.50.950.940.990.780.560.60.990.660.980.970.990.990.970.99
0.750.990.890.930.980.990.830.990.790.610.650.960.90.990.850.640.710.980.750.910.970.950.940.960.99
0.580.980.990.970.990.960.770.980.710.760.410.930.940.980.750.490.520.980.610.990.990.951.00.950.97
0.590.970.990.980.980.960.770.980.70.780.390.920.930.980.730.480.520.980.611.00.990.941.00.950.96
0.660.980.90.950.970.980.90.970.850.640.590.940.890.980.810.550.670.970.670.920.970.960.950.950.98
0.741.00.920.960.991.00.860.990.80.660.60.970.910.990.80.610.70.990.740.940.990.990.970.960.98
Click cells to compare fundamentals

Globus Medical Account Relationship Matchups

Globus Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding102.0M101.0M103.6M102.6M114.6M104.1M
Total Assets1.5B1.7B2.0B2.1B5.1B5.3B
Other Current Liab6.7M93.4M105.1M105.5M301.5M316.6M
Total Current Liabilities111.4M120.8M140.2M159.2M392.3M412.0M
Total Stockholder Equity1.4B1.5B1.7B1.8B4.0B4.2B
Other Liab17.1M52.4M75.7M70.5M81.1M85.2M
Property Plant And Equipment Net199.8M216.9M221.1M243.7M646.9M679.2M
Current Deferred Revenue5.4M8.1M12.0M14.1M18.4M9.6M
Net Debt(193.2M)(234.6M)(188.0M)(144.5M)53.1M55.8M
Retained Earnings1.0B1.0B1.2B1.2B1.1B764.6M
Accounts Payable24.6M18.2M22.0M36.1M56.7M59.5M
Cash195.7M239.4M193.1M150.5M467.3M490.7M
Non Current Assets Total844.6M857.7M1.1B1.1B3.2B3.3B
Non Currrent Assets Other21.7M32.0M36.3M43.3M78.6M82.5M
Other Assets25.2M209.8M60.8M92.2M106.0M111.3M
Cash And Short Term Investments311.5M426.7M443.4M446.1M517.8M342.9M
Net Receivables162.4M148.1M165.7M217.3M504.9M530.1M
Liabilities And Stockholders Equity1.5B1.7B2.0B2.1B5.1B5.3B
Non Current Liabilities Total18.2M52.4M75.7M70.5M695.8M730.6M
Inventory196.3M229.2M237.0M299.0M848.1M890.5M
Other Current Assets17.2M17.8M18.4M21.0M44.6M46.8M
Other Stockholder Equity357.3M457.2M553.8M631.0M2.9B3.0B
Total Liab129.6M173.2M215.9M229.8M1.1B1.1B
Property Plant And Equipment Gross199.8M216.9M526.7M586.8M1.1B1.1B
Total Current Assets687.5M821.8M864.5M983.3M1.9B2.0B
Accumulated Other Comprehensive Income(2.9M)4.0M(6.8M)(24.6M)(10.2M)(9.7M)
Short Term Debt74.7M88.7M94.4M2.5M12.0M11.4M
Property Plant Equipment202.3M216.9M221.1M243.7M280.3M146.5M
Good Will128.8M156.7M179.7M197.5M1.4B1.5B
Intangible Assets78.8M86.9M68.7M63.6M924.6M970.8M
Net Tangible Assets1.2B1.3B1.5B1.6B1.8B981.4M
Short Term Investments115.8M187.3M250.4M295.6M50.5M48.0M
Capital Surpluse357.3M457.2M553.8M631.0M725.6M761.9M
Non Current Liabilities Other12.2M46.2M71.4M68.8M102.9M108.1M
Long Term Investments409.5M358.5M562.5M495.9M75.4M71.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
42.231
Earnings Share
0.62
Revenue Per Share
18.217
Quarterly Revenue Growth
0.631
Return On Assets
0.0473
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.